Partnering for Innovation
Innovation at Boehringer Ingelheim is founded in the Company’s desire to discover and develop new medications of high therapeutic value. Partnerships between our own team of highly experienced scientists and our growing global network of academic and industry partners, provide a rich source of fuel for Boehringer Ingelheim’s research and development engine. With an active investment program in external partnerships, we are seeking opportunities across the entire drug discovery and development value chain, so together we can improve the health of people around the world.
Our Partnering Interests
Our partnering activities encompass:
- Focusing on the discovery and development of new and/or better medications for patients in our areas of therapeutic focus
- Identifying and exploring dynamic research fields such as immune modulation and biotherapeutics’ discovery which may impact and create synergies across our therapeutic areas
- Harnessing emerging science and technology within and beyond our therapeutic areas – Research Beyond Borders.